Toxic liver disease with chronic persistent hepatitis
ICD-10 K71.3 is a billable code used to indicate a diagnosis of toxic liver disease with chronic persistent hepatitis.
Toxic liver disease with chronic persistent hepatitis (K71.3) is characterized by liver inflammation resulting from exposure to hepatotoxic substances, such as drugs, alcohol, or industrial chemicals. Clinically, patients may present with symptoms including fatigue, jaundice, abdominal pain, and elevated liver enzymes. The liver, a vital organ in the digestive system, plays a crucial role in metabolizing substances and detoxifying harmful compounds. Chronic persistent hepatitis indicates a prolonged inflammatory response, which can lead to fibrosis and potentially progress to cirrhosis if the toxic exposure continues. Diagnosis typically involves a thorough patient history, physical examination, laboratory tests (including liver function tests), and imaging studies to assess liver structure and function. In some cases, a liver biopsy may be necessary to confirm the diagnosis and rule out other liver diseases. Early identification and management of toxic liver disease are essential to prevent further liver damage and associated complications.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
K71.3 covers chronic persistent hepatitis resulting from toxic exposure, including drug-induced liver injury and chronic alcohol-related liver disease. It is essential to document the specific toxic agent involved.
K71.3 should be used when there is clear evidence of chronic liver inflammation due to toxic exposure, as opposed to acute conditions or other liver diseases that do not involve chronicity.
Documentation should include a detailed history of exposure to hepatotoxic substances, clinical symptoms, laboratory results indicating liver function, and any imaging or biopsy findings that support the diagnosis of chronic persistent hepatitis.
